Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Barac

Showing results (141-150 of 167) with videos related to

Pageof 17
Sort By:
Leukemia & Lymphoma|April 8, 2025
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failureEmily Anderson, Yun Choi, Rachel J Buchsbaum, et al.
Cancer|November 5, 2020
Cardiometabolic risk factors and survival after cancer in the Women's Health InitiativeMichael S Simon, Theresa A Hastert, Ana Barac, et al.
Trends in Cardiovascular Medicine|June 1, 2020
Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) PandemicSarju Ganatra, Sourbha S Dani, Sachin Shah, et al.
Journal of the National Cancer Institute|November 12, 2020
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging CouncilsLauren A Baldassarre, Eric H Yang, Richard K Cheng, et al.
JACC. Cardiooncology|April 17, 2025
Quality-of-Care Measures for Cardio-Oncology: An IC-OS and ACC Cardio-Oncology Leadership Council PerspectiveVijay U Rao, Anita Deswal, Daniel Lenihan, et al.
Cancer|July 16, 2024
Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortalityPinkal Desai, Ying Zhou, Justin Grenet, et al.
Neurology|January 3, 2024
Radon Exposure, Clonal Hematopoiesis, and Stroke Susceptibility in the Women's Health InitiativeKurtis M Anthony, Jason M Collins, Shelly-Ann M Love, et al.
Journal of the National Cancer Institute|May 29, 2026
Statins and risk of cardiovascular disease: Emulating a primary prevention trial in breast cancer survivorsRienna G Russo, Miguel A Hernán, Issa J Dahabreh, et al.
European Heart Journal|December 14, 2021
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statementJoerg Herrmann, Daniel Lenihan, Saro Armenian, et al.
JACC. Cardiooncology|January 13, 2025
SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With DiabetesAmmar W Bhatti, Rushin Patel, Sourbha S Dani, et al.
Pageof 17

Showing results (141-150 of 167) with videos related to

Sort By:
Pageof 17
Leukemia & Lymphoma|April 8, 2025
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failureEmily Anderson, Yun Choi, Rachel J Buchsbaum, et al.
Cancer|November 5, 2020
Cardiometabolic risk factors and survival after cancer in the Women's Health InitiativeMichael S Simon, Theresa A Hastert, Ana Barac, et al.
Trends in Cardiovascular Medicine|June 1, 2020
Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) PandemicSarju Ganatra, Sourbha S Dani, Sachin Shah, et al.
Journal of the National Cancer Institute|November 12, 2020
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging CouncilsLauren A Baldassarre, Eric H Yang, Richard K Cheng, et al.
JACC. Cardiooncology|April 17, 2025
Quality-of-Care Measures for Cardio-Oncology: An IC-OS and ACC Cardio-Oncology Leadership Council PerspectiveVijay U Rao, Anita Deswal, Daniel Lenihan, et al.
Cancer|July 16, 2024
Association of clonal hematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortalityPinkal Desai, Ying Zhou, Justin Grenet, et al.
Neurology|January 3, 2024
Radon Exposure, Clonal Hematopoiesis, and Stroke Susceptibility in the Women's Health InitiativeKurtis M Anthony, Jason M Collins, Shelly-Ann M Love, et al.
Journal of the National Cancer Institute|May 29, 2026
Statins and risk of cardiovascular disease: Emulating a primary prevention trial in breast cancer survivorsRienna G Russo, Miguel A Hernán, Issa J Dahabreh, et al.
European Heart Journal|December 14, 2021
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statementJoerg Herrmann, Daniel Lenihan, Saro Armenian, et al.
JACC. Cardiooncology|January 13, 2025
SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With DiabetesAmmar W Bhatti, Rushin Patel, Sourbha S Dani, et al.
Pageof 17